Medeikon Corporation Announces Collaboration With American Cardiovascular Research Institute

EWING, N.J.--(BUSINESS WIRE)--March 10, 2006--Medeikon Announces Collaboration with ACRI to Leverage and Combine Best-in-Class Technology to Identify and Treat Cardiac Disease Medeikon Corporation provides medical devices that enable physicians to accurately diagnose and treat cardiovascular disease. Medeikon's initial emphasis is on rupture-prone plaque, the leading cause of sudden cardiac death. Medeikon's XploraPD(TM) system helps physician's distinguish these rupture-prone lesions from other types of coronary artery tissue using optical technologies. This allows physicians to make early and accurate diagnosis and then treat the condition with tools consistent with current cardiac catheterization techniques and equipment.